SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).
Adjuvant
Early breast cancer
Follow-up
Neoadjuvant
Journal
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
ISSN: 1699-3055
Titre abrégé: Clin Transl Oncol
Pays: Italy
ID NLM: 101247119
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
04
05
2023
accepted:
05
05
2023
medline:
15
8
2023
pubmed:
16
6
2023
entrez:
16
6
2023
Statut:
ppublish
Résumé
Breast cancer is the leading cause of cancer in women in Spain and its annual incidence is rapidly increasing. Thanks to the screening programs in place, nearly 90% of breast cancer cases are detected in early and potentially curable stages, despite the COVID-19 pandemic possibly having impacted these numbers (not yet quantified). In recent years, locoregional and systemic therapies are increasingly being directed by new diagnostic tools that have improved the balance between toxicity and clinical benefit. New therapeutic strategies, such as immunotherapy, targeted drugs, and antibody-drug conjugates have also improved outcomes in some patient subgroups. This clinical practice guideline is based on a systematic review of relevant studies and on the consensus of experts from GEICAM, SOLTI, and SEOM.
Identifiants
pubmed: 37326826
doi: 10.1007/s12094-023-03215-4
pii: 10.1007/s12094-023-03215-4
pmc: PMC10425528
doi:
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2647-2664Commentaires et corrections
Type : CommentIn
Type : ErratumIn
Informations de copyright
© 2023. The Author(s).
Références
Semin Oncol. 2020 Aug;47(4):209-216
pubmed: 32513420
Br J Cancer. 2013 Dec 10;109(12):2959-64
pubmed: 24157828
J Clin Oncol. 2009 May 20;27(15):2474-81
pubmed: 19332727
J Clin Oncol. 2009 Mar 10;27(8):1177-83
pubmed: 19204201
Clin Cancer Res. 2016 Feb 1;22(3):560-6
pubmed: 26152740
J Clin Oncol. 2020 Dec 1;38(34):3987-3998
pubmed: 32954927
J Natl Cancer Inst. 2021 Jul 1;113(7):808-819
pubmed: 33369635
J Clin Oncol. 2019 Aug 1;37(22):1868-1875
pubmed: 30939096
JAMA. 2017 Sep 12;318(10):918-926
pubmed: 28898379
N Engl J Med. 2023 Feb 16;388(7):585-594
pubmed: 36791159
Breast Cancer Res Treat. 2012 Jan;131(1):117-26
pubmed: 21935602
N Engl J Med. 2004 Dec 30;351(27):2817-26
pubmed: 15591335
J Clin Oncol. 2017 Jun 20;35(18):2062-2081
pubmed: 28618241
J Clin Oncol. 2006 Oct 20;24(30):4888-94
pubmed: 17015884
Lancet. 2019 Apr 6;393(10179):1440-1452
pubmed: 30739743
Ann Oncol. 2018 Jul 1;29(7):1497-1508
pubmed: 29873695
Ann Oncol. 2017 Nov 1;28(11):2899
pubmed: 27634692
Arch Pathol Lab Med. 2018 Nov;142(11):1364-1382
pubmed: 29846104
Lancet. 2005 Aug 6-12;366(9484):455-62
pubmed: 16084253
Ann Oncol. 2022 Apr;33(4):384-394
pubmed: 35093516
Breast Cancer Res Treat. 2019 Jan;173(2):247-254
pubmed: 30317424
J Clin Oncol. 2022 Jun 1;40(16):1816-1837
pubmed: 35439025
Lancet. 2012 Feb 4;379(9814):432-44
pubmed: 22152853
Breast Cancer Res Treat. 2019 Jan;173(2):267-274
pubmed: 30361873
J Clin Oncol. 2011 Jun 10;29(17):2342-9
pubmed: 21555689
Ann Surg Oncol. 2018 Dec;25(13):3867-3873
pubmed: 30242775
Elife. 2022 Jun 10;11:
pubmed: 35686727
Lancet Oncol. 2020 Nov;21(11):1443-1454
pubmed: 33152284
Lancet Oncol. 2020 Apr;21(4):519-530
pubmed: 32171426
Breast Cancer Res Treat. 2013 Jan;137(2):465-70
pubmed: 23224235
J Clin Oncol. 2020 Apr 20;38(12):1346-1366
pubmed: 31928404
Lancet Oncol. 2021 Apr;22(4):476-488
pubmed: 33721561
Front Oncol. 2017 Aug 03;7:156
pubmed: 28824872
N Engl J Med. 2021 Dec 16;385(25):2336-2347
pubmed: 34914339
Breast Cancer Res Treat. 2019 Jan;173(1):103-109
pubmed: 30238273
Lancet. 2020 May 23;395(10237):1613-1626
pubmed: 32580883
J Clin Oncol. 2010 Apr 20;28(12):2114-22
pubmed: 20308661
J Clin Oncol. 2006 Aug 10;24(23):3726-34
pubmed: 16720680
Ann Oncol. 2008 Apr;19(4):614-22
pubmed: 18024988
N Engl J Med. 2022 Feb 10;386(6):556-567
pubmed: 35139274
Lancet. 2015 Oct 3;386(10001):1341-1352
pubmed: 26211827
Breast Care (Basel). 2019 Apr;14(2):103-110
pubmed: 31798382
Lancet. 2005 May 14-20;365(9472):1687-717
pubmed: 15894097
Nature. 2000 Aug 17;406(6797):747-52
pubmed: 10963602
Lancet. 2017 Mar 25;389(10075):1195-1205
pubmed: 28215665
NPJ Breast Cancer. 2020 Jun 8;6:21
pubmed: 32550266
N Engl J Med. 2016 Aug 25;375(8):717-29
pubmed: 27557300
Ann Oncol. 2012 Dec;23(12):3069-3074
pubmed: 22674146
J Clin Oncol. 2014 Nov 20;32(33):3744-52
pubmed: 25332249
Ann Oncol. 2019 Oct 1;30(10):1541-1557
pubmed: 31373601
Lancet Oncol. 2014 Nov;15(12):1303-10
pubmed: 25439688
JAMA Surg. 2015 Aug;150(8):778-86
pubmed: 26083835
N Engl J Med. 2004 Mar 11;350(11):1081-92
pubmed: 15014181
Lancet. 2020 Oct 10;396(10257):1090-1100
pubmed: 32966830
Lancet Oncol. 2023 Mar;24(3):273-285
pubmed: 36858723
N Engl J Med. 2009 Aug 20;361(8):766-76
pubmed: 19692688
Ann Oncol. 2013 Sep;24(9):2278-84
pubmed: 23704196
N Engl J Med. 2018 Jul 12;379(2):111-121
pubmed: 29860917
J Clin Oncol. 2005 Aug 1;23(22):5138-47
pubmed: 16009955
N Engl J Med. 2015 Nov 19;373(21):2005-14
pubmed: 26412349
Eur J Pharmacol. 2013 Oct 5;717(1-3):71-83
pubmed: 23545364
J Clin Oncol. 2005 Aug 1;23(22):5108-16
pubmed: 15998903
Ann Surg Oncol. 2016 Oct;23(10):3190-8
pubmed: 27406093
CA Cancer J Clin. 2017 Jul 8;67(4):290-303
pubmed: 28294295
Ann Oncol. 2019 Nov 1;30(11):1776-1783
pubmed: 31504126
Eur J Cancer. 2022 May;166:185-201
pubmed: 35305453
Lancet Oncol. 2013 Oct;14(11):1067-1076
pubmed: 24035531
Lancet. 2013 Mar 9;381(9869):805-16
pubmed: 23219286
Lancet Oncol. 2012 Jan;13(1):25-32
pubmed: 22153890
J Clin Oncol. 2021 May 1;39(13):1448-1457
pubmed: 33539215
Ann Oncol. 2017 Aug 1;28(8):1700-1712
pubmed: 28838210
Breast Cancer Res Treat. 2015 Nov;154(1):99-103
pubmed: 26467045
Cancers (Basel). 2021 Mar 29;13(7):
pubmed: 33805367
JCO Oncol Pract. 2021 Dec;17(12):697-706
pubmed: 34652952
Lancet Oncol. 2018 Jan;19(1):40-50
pubmed: 29233559
Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):474-486
pubmed: 28330818
JAMA Oncol. 2023 Jun 1;9(6):835-840
pubmed: 37103927
N Engl J Med. 2015 Jul 23;373(4):307-16
pubmed: 26200977
N Engl J Med. 2019 Feb 14;380(7):617-628
pubmed: 30516102
Clin Cancer Res. 2017 Dec 1;23(23):7217-7224
pubmed: 28939745
Clin Infect Dis. 2010 Nov 15;51(10):1147-56
pubmed: 20946067
Breast. 2011 Dec;20(6):491-4
pubmed: 21807517
Lancet. 2005 Jan 1-7;365(9453):60-2
pubmed: 15639680
EBioMedicine. 2022 Jan;75:103801
pubmed: 34990895
Clin Transl Oncol. 2018 Jun;20(6):687-694
pubmed: 29139040
Histopathology. 2020 Aug;77(2):181-185
pubmed: 32056259
Lancet Oncol. 2017 Sep;18(9):1211-1220
pubmed: 28732650
Breast. 2019 Aug;46:19-24
pubmed: 31051411
Clin Breast Cancer. 2021 Feb;21(1):80-91.e7
pubmed: 33183970
Lancet. 2014 Jul 12;384(9938):164-72
pubmed: 24529560
Ann Oncol. 2014 Feb;25(2):339-45
pubmed: 24347518
Lancet. 2007 May 19;369(9574):1711-23
pubmed: 17512856
Cancer. 2020 Aug 15;126 Suppl 16:3837-3846
pubmed: 32710666
Ann Surg. 2019 Mar;269(3):432-442
pubmed: 30312200
Ann Oncol. 2019 Aug 1;30(8):1194-1220
pubmed: 31161190
J Clin Oncol. 2020 Jun 20;38(18):2080-2106
pubmed: 32243226
Lancet Oncol. 2010 Jan;11(1):55-65
pubmed: 20005174
Eur J Cancer. 2010 May;46(8):1296-316
pubmed: 20304629
Cancers (Basel). 2020 Apr 08;12(4):
pubmed: 32276534
N Engl J Med. 2011 Oct 6;365(14):1273-83
pubmed: 21991949
Lancet Oncol. 2012 Apr;13(4):345-52
pubmed: 22265697
N Engl J Med. 2018 Jul 12;379(2):122-137
pubmed: 29863451
JAMA Oncol. 2021 Jul 01;7(7):978-984
pubmed: 34014249
J Clin Oncol. 2018 Mar 10;36(8):735-740
pubmed: 29369732
N Engl J Med. 2021 Jun 24;384(25):2394-2405
pubmed: 34081848
JAMA Oncol. 2023 Jun 1;9(6):841-846
pubmed: 37103916